Vilin Bio Med Limited — JV/Acquisition, 16-02-2026: Amalgamation/Merger

Vilin Bio Med is merging with Chemgenix Laboratories (CLPL) to boost scale, diversify its product portfolio, and unlock synergies in pharma manufacturing and APIs. The merger features a 1:1 share swap, meaning one Vilin share for every CLPL share. Post-merger, Vilin's promoter stake will rise from 63.65% to 74.45%, while non-promoter holding will see dilution, decreasing from 36.35% to 25.55%. As of Dec 2025, CLPL reported a net worth of ₹13.52 Cr and turnover of ₹32.44 Cr, while Vilin had a net worth of ₹23.76 Cr and turnover of ₹21.06 Cr.